DPPX Autoimmune Encephalitis Presenting with Chorea
Objective: To report a case of a rare autoimmune disorder associated with dipeptidyl-peptidase-like protein- 6 (DPPX) antibodies, highlighting its classical features, diagnostic challenges, and therapeutic…Impact of Gastrointestinal Dysfunction Symptoms on Psychomotor Recovery Following 8-Week Aerobic Interval Training in Parkinson’s Disease – Preliminary Results
Objective: To investigate the impact of gastrointestinal dysfunction symptoms (GIDS) on psychomotor recovery following 8-week aerobic interval training (AIT) in Parkinson's disease (PD). Background: GIDS…NIH funds Gut-Brain Parkinson’s Disease Consortium
Objective: Describe the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) multicenter (UO1) Consortium on PD Gut-Brain Communication. Background: A 2024 Notice of Funding…Turkish Validity and Reliability Study of the Gastrointestinal Dysfunction Scale for Parkinson’s Disease
Objective: The aim of this study is to make a Turkish adaptation of the "Gastrointestinal Dysfunction Scale for PD (GIDS-PD)"and detect gastrointestinal symptoms at an…Helicobacter Pylori Infection, Peptic Ulcer, Gastritis and Risk of Parkinson´s Disease: a Nationwide Matched Cohort Study
Objective: To examine the potential link between H. pylori infection, gastritis, peptic ulcer and Parkinson’s Disease (PD) risk. Background: Gastrointestinal disorders are frequent among PD…A Randomized, Double-Blind, Placebo-Controlled Trial of a Multi-Strain Probiotic for Anxiety in Parkinson’s Disease
Objective: To evaluate the effect of a multi-strain probiotic on anxiety in patients with Parkinson’s disease (PD). Background: There is a lack of dedicated randomized…Therapeutic restoration of Faecalibacterium prausnitzii in Parkinson’s disease using targeted fructoligosaccharides: a double-blind, placebo-controlled, cross-over trial
Objective: In this study, we evaluated the effect of targeted fructoligosaccharide (FOS) therapy to restore the beneficial butyrate producer Faecalibacterium prausnitzii, one the most highly reduced…Gut Microbiota May Alter Glucose Metabolism in Patients with Parkinson’s Disease
Objective: To compare the gut microbiota in patients with Parkinson’s disease (PD) and healthy controls and predict the functional pathways associated with these differences. Background:…Altered gut microbiota composition and metabolism in Parkinson’s disease
Objective: To define changes in gut microbiota composition and metabolism to enable identification of novel therapeutic targets and strategies for disease modification. Background: Multiple cohort…Exploring the Influence of Gastrointestinal Symptoms on Non-Motor Fluctuations in Parkinson’s Disease: Insights from the ReMePark-2, a Mexican Cohort
Objective: To determine the impact of gastrointestinal symptoms on NMF in PD among Mexican individuals living with PD (PwP). Background: The growing interest in the…
- 1
- 2
- 3
- …
- 11
- Next Page »